» Authors » Mahmood B Aldapt

Mahmood B Aldapt

Explore the profile of Mahmood B Aldapt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 63
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdulla M, Aldapt M, Chandra P, El Akiki S, Alshurafa A, Nashwan A, et al.
Oncology . 2024 Jul; 102(12):1018-1028. PMID: 39013365
Introduction: Adolescents and young adults (AYAs) diagnosed with chronic myeloid leukemia (CML) constitute a significant demographic group, particularly in regions with youthful populations like Qatar. Despite the global median age...
2.
Elsabah H, Ghasoub R, Soliman D, Ibrahim F, Aldapt M, Y Taha R, et al.
Cancer Rep (Hoboken) . 2024 Jul; 7(7):e2106. PMID: 38967112
Background: Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated...
3.
Ata F, Benkhadra M, Ghasoub R, Fernyhough L, Omar N, Nashwan A, et al.
Front Oncol . 2024 Jan; 13:1285346. PMID: 38188307
Tyrosine Kinase Inhibitors (TKIs) is revolutionizing the management of pediatric Chronic Myeloid Leukemia (CML), offering alternatives to Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT). We conducted a comprehensive review of 16...
4.
Aldapt M, Al-Mashdali A, Obeidat K, Chandra P, Yassin M
Oncology . 2023 Oct; 102(4):380-388. PMID: 37848004
Background: Viral infections remain a significant problem for patients with chronic myeloid leukemia (CML) who undergo stem cell transplants (SCTs). These infections often result from the reactivation of latent viruses....
5.
Al-Mashdali A, Aldapt M, Rahhal A, Hailan Y, Elhakeem I, Ali E, et al.
Diagnostics (Basel) . 2023 Feb; 13(3). PMID: 36766480
Background: Philadelphia-negative myeloproliferative neoplasms (MPN) are most prevalent in the older population (median age at the diagnosis is above 60 years) and rarely diagnosed in pediatrics. Thus, our knowledge about...
6.
Yassin M, Soliman A, Hmissi S, Abdulla M, Itani M, Alamami A, et al.
Medicine (Baltimore) . 2022 Sep; 101(36):e30431. PMID: 36086749
Neutropenia ranges from a normal variant to life-threatening acquired and congenital disorders. This study aims at providing baseline information regarding the prevalence and spectrum of neutropenia in the Arab blood...
7.
Yassin M, Soliman A, Nashwan A, Alamami A, Abdulla M, Hmissi S, et al.
Medicine (Baltimore) . 2022 Jun; 101(24):e29271. PMID: 35713431
Hematologic reference intervals vary with gender, age, ethnicity, and geographic area. Therefore, local or national laboratory reference ranges are essential to enhance the accuracy when diagnosing health conditions. Still, no...
8.
Abdulla M, Chandra P, El Akiki S, Aldapt M, Sardar S, Chapra A, et al.
Cancer Control . 2021 Nov; 28:10732748211038429. PMID: 34789006
Objective: It is debatable whether BCR-ABL1 transcript type has an impact on outcome of treatment of patients with CML, and it is not widely studied whether body weight influences response...
9.
Basha A, Ibrahim M, Hamad A, Chandra P, Omar N, Abdullah M, et al.
PLoS One . 2021 Aug; 16(8):e0255104. PMID: 34375369
Background: Iron deficiency anaemia (IDA) is a major health issues and common type of nutritional deficiency worldwide. For IDA treatment, intravenous (IV) iron is a useful therapy. Objective: To determine...
10.
Aldapt M, Yassin M
Acta Biomed . 2021 May; 92(2):e2021192. PMID: 33988158
Background And Objective: Cutaneous infiltration by Chronic Lymphocytic Leukemia (CLL) is a rare complication. The clinical presentation, impact of it on disease prognosis, and the proper treatment choice are not...